TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs

Overview of attention for article published in Journal of Clinical Investigation, September 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 27 patents
wikipedia: 6 Wikipedia pages

guideline: 1 clinical guideline source

Readers on

mendeley: 157 Mendeley
connotea: 1 Connotea

So far, Altmetric has seen 1 Guideline that references this research output.

Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice

Clinical guideline published by Pediatric Endocrine Society (PES) on 30 Apr 2024

The Pediatric Endocrine Society (PES) is dedicated to advancing the endocrine health of children, adolescents, and young adults. It provides resources for healthcare professionals and patients, including clinical guidelines, educational materials, and support for pediatric endocrinologists.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.